616
Participants
Start Date
November 20, 2022
Primary Completion Date
November 20, 2024
Study Completion Date
November 20, 2039
Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
Experimental group receive HIPEC two times after laproscopic gastrectomy
RECRUITING
The Affiliated Hospital of Qingdao University, Qingdao
Shandong Cancer Hospital and Institute
OTHER
Chinese PLA General Hospital
OTHER
Zibo Central Hospital
OTHER_GOV
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
OTHER
Jinan Central Hospital
OTHER
Qilu Hospital of Shandong University
OTHER
Yantai Yuhuangding Hospital
OTHER
Nanfang Hospital, Southern Medical University
OTHER
Shandong First Medical University
OTHER
The First Affiliated Hospital of Nanchang University
OTHER
Hebei Medical University Fourth Hospital
OTHER
Peking University Cancer Hospital & Institute
OTHER
Peking University People's Hospital
OTHER
Tianjin Cancer Hospital
UNKNOWN
First Affiliated Hospital of Xi 'an Jiaotong University
UNKNOWN
Union Hospital of Huazhong University of Science and Technology
UNKNOWN
Wuhan University
OTHER
Brigham and Women's Hospital
OTHER
The Second Xiangya College of Central South University
UNKNOWN
Weihai Municipal Hospital
OTHER
Mountain University Cancer Hospital
UNKNOWN
Ruijin Hospital
OTHER
The Affiliated Hospital of Qingdao University
OTHER